$194.23
-0.8-0.41%
At Close: -
$193.00
-1.23-0.63%
After Hours: 4:27 PM EDT
15 minutes delayed
Comments
Loading...
Insulet
PODDNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Insulet (NASDAQ:PODD) Stock, Analyst Ratings, Price Targets, Forecasts
Insulet Corp has a consensus price target of $256.56 based on the ratings of 26 analysts. The high is $350 issued by BTIG on April 17, 2023. The low is $184 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Redburn Atlantic, Barclays, and Canaccord Genuity on May 30, 2024, May 13, 2024, and May 10, 2024, respectively. With an average price target of $223 between Redburn Atlantic, Barclays, and Canaccord Genuity, there's an implied 15.54% upside for Insulet Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Redburn Atlantic
Barclays
Canaccord Genuity
Raymond James
Jefferies
1calculated from analyst ratings
Analyst Ratings for Insulet
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/10/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 05/30/2024 | Buy Now | 21.76% | Redburn Atlantic | Issie Kirby | → $235 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | 3.63% | Barclays | Matt Miksic | $213 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 21.24% | Canaccord Genuity | Kyle Rose | $226 → $234 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 10.36% | Raymond James | Jayson Bedford | $218 → $213 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | 34.72% | Jefferies | Matthew Taylor | $255 → $260 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 3.63% | Wolfe Research | Mike Polark | → $200 | Upgrade | Peer Perform → Outperform | Get Alert |
| 02/26/2024 | Buy Now | 10.36% | Barclays | Matt Miksic | $214 → $213 | Maintains | Equal-Weight | Get Alert |
| 02/23/2024 | Buy Now | 19.17% | Piper Sandler | Matt O'Brien | $250 → $230 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 16.58% | JP Morgan | Robbie Marcus | $190 → $225 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | 7.77% | Stifel | Mathew Blackman | $163 → $208 | Maintains | Hold | Get Alert |
| 12/21/2023 | Buy Now | 23.32% | Baird | Jeff Johnson | $180 → $238 | Upgrade | Neutral → Outperform | Get Alert |
| 12/04/2023 | Buy Now | 21.24% | Morgan Stanley | Patrick Wood | $185 → $234 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | 29.53% | Piper Sandler | Matt O'Brien | $325 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -16.06% | JP Morgan | Robbie Marcus | $325 → $162 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -4.66% | Leerink Partners | Mike Kratky | → $184 | Initiates | → Outperform | Get Alert |
| 10/02/2023 | Buy Now | 24.35% | Jefferies | Matthew Taylor | $260 → $240 | Upgrade | Hold → Buy | Get Alert |
| 09/29/2023 | Buy Now | -4.15% | Morgan Stanley | Patrick Wood | $208 → $185 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 18.13% | Raymond James | Jayson Bedford | $299 → $228 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | 11.4% | UBS | Matthew Taylor | $270 → $215 | Maintains | Neutral | Get Alert |
| 08/24/2023 | Buy Now | 52.85% | B of A Securities | Travis Steed | $365 → $295 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | 7.77% | Morgan Stanley | Patrick Wood | $343 → $208 | Maintains | Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | 37.31% | Citigroup | Joanne Wuensch | $273 → $265 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | Buy Now | 13.47% | Baird | Jeff Johnson | $320 → $219 | Downgrade | Outperform → Neutral | Get Alert |
| 08/10/2023 | Buy Now | 33.16% | Barclays | Matt Miksic | $329 → $257 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | 55.44% | TD Cowen | Josh Jennings | $350 → $300 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | 68.39% | JP Morgan | Robbie Marcus | $365 → $325 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 41.45% | Citigroup | Joanne Wuensch | $319 → $273 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 70.98% | Wells Fargo | Lawrence Biegelsen | $375 → $300 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | 54.92% | Raymond James | Jayson Bedford | $350 → $299 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 65.28% | Citigroup | Joanne Wuensch | $330 → $319 | Maintains | Neutral | Get Alert |
| 05/30/2023 | Buy Now | 77.72% | Morgan Stanley | Patrick Wood | → $343 | Assumes | → Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 70.47% | Barclays | Matt Miksic | $292 → $329 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 77.72% | Morgan Stanley | Cecilia Furlong | $325 → $343 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 81.35% | Raymond James | Jayson Bedford | $334 → $350 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 86.53% | Piper Sandler | Matt O'Brien | $340 → $360 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 91.71% | Baird | Jeff Johnson | $350 → $370 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 77.2% | Stifel | Mathew Blackman | $300 → $342 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 81.35% | BTIG | Ryan Zimmerman | $340 → $350 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 73.06% | Raymond James | Jayson Bedford | $320 → $334 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 68.39% | Morgan Stanley | Cecilia Furlong | $320 → $325 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | 81.35% | Baird | Jeff Johnson | $340 → $350 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | — | Wolfe Research | Mike Polark | — | Initiates | → Peer Perform | Get Alert |
| 01/06/2023 | Buy Now | 65.8% | Morgan Stanley | Cecilia Furlong | $300 → $320 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 55.44% | Morgan Stanley | David Lewis | $273 → $300 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 63.21% | Baird | Jeff Johnson | $300 → $315 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 65.8% | Raymond James | Jayson Bedford | $280 → $320 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 76.17% | Piper Sandler | Matt O'Brien | $235 → $340 | Upgrade | Neutral → Overweight | Get Alert |
| 10/18/2022 | Buy Now | 23.32% | Barclays | Matt Miksic | → $238 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 34.72% | Jefferies | Matthew Taylor | → $260 | Initiates | → Hold | Get Alert |
| 08/22/2022 | Buy Now | 60.62% | TD Cowen | Josh Jennings | → $310 | Maintains | Outperform | Get Alert |
| 08/08/2022 | Buy Now | 41.45% | Morgan Stanley | David Lewis | $244 → $273 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | 50.26% | Canaccord Genuity | Kyle Rose | $250 → $290 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | 55.44% | Baird | Jeff Johnson | $245 → $300 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 45.08% | Raymond James | Jayson Bedford | $262 → $280 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 21.76% | Piper Sandler | Matt O'Brien | $230 → $235 | Maintains | Neutral | Get Alert |
| 07/11/2022 | Buy Now | 29.53% | Citigroup | Joanne Wuensch | $310 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 06/24/2022 | Buy Now | 29.53% | BTIG | Marie Thibault | $310 → $250 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | 26.42% | Morgan Stanley | David Lewis | $268 → $244 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 60.62% | Citigroup | Joanne Wuensch | $350 → $310 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | 35.75% | Raymond James | Jayson Bedford | $280 → $262 | Maintains | Outperform | Get Alert |
| 05/06/2022 | Buy Now | 45.08% | SVB Leerink | Danielle Antalffy | $300 → $280 | Maintains | Outperform | Get Alert |
| 03/02/2022 | Buy Now | — | B of A Securities | Travis Steed | — | Reinstates | → Buy | Get Alert |
| 02/25/2022 | Buy Now | 38.86% | Morgan Stanley | David Lewis | $300 → $268 | Maintains | Equal-Weight | Get Alert |
| 02/24/2022 | Buy Now | 45.08% | Raymond James | Jayson Bedford | $329 → $280 | Maintains | Outperform | Get Alert |
| 02/24/2022 | Buy Now | 19.17% | Piper Sandler | Matthew O'Brien | $295 → $230 | Maintains | Neutral | Get Alert |
| 02/03/2022 | Buy Now | 65.8% | BTIG | Sean Lavin | → $320 | Upgrade | Neutral → Buy | Get Alert |
| 02/02/2022 | Buy Now | 68.39% | UBS | Matthew Taylor | → $325 | Upgrade | Neutral → Buy | Get Alert |
| 01/31/2022 | Buy Now | 42.49% | Oppenheimer | Steven Lichtman | $300 → $275 | Upgrade | Perform → Outperform | Get Alert |
| 01/07/2022 | Buy Now | 55.44% | Morgan Stanley | David Lewis | $303 → $300 | Maintains | Equal-Weight | Get Alert |
| 11/08/2021 | Buy Now | 70.47% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
| 11/05/2021 | Buy Now | 56.99% | Morgan Stanley | David Lewis | — | Maintains | Equal-Weight | Get Alert |
| 11/05/2021 | Buy Now | 81.35% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 08/06/2021 | Buy Now | 55.44% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Insulet (PODD) stock?
The latest price target for Insulet (NASDAQ:PODD) was reported by OTR Global on June 10, 2024. The analyst firm set a price target for $0.00 expecting PODD to fall to within 12 months (a possible -100.00% downside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insulet (PODD)?
The latest analyst rating for Insulet (NASDAQ:PODD) was provided by OTR Global, and Insulet downgraded their mixed rating.
When was the last upgrade for Insulet (PODD)?
The last upgrade for Insulet Corp happened on May 7, 2024 when Wolfe Research raised their price target to $200. Wolfe Research previously had a peer perform for Insulet Corp.
When was the last downgrade for Insulet (PODD)?
The last downgrade for Insulet Corp happened on June 10, 2024 when OTR Global changed their price target from N/A to N/A for Insulet Corp.
When is the next analyst rating going to be posted or updated for Insulet (PODD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insulet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insulet was filed on June 10, 2024 so you should expect the next rating to be made available sometime around June 10, 2025.
Is the Analyst Rating Insulet (PODD) correct?
While ratings are subjective and will change, the latest Insulet (PODD) rating was a downgraded with a price target of $0.00 to $0.00. The current price Insulet (PODD) is trading at is $193.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.